DTx Pharma Completes $100M Series B Financing to Advance its FALCON™ Platform and Pipeline of RNA Therapeutics

2021-03-01T05:03:12-08:00March 1st, 2021|

Proceeds will enable further platform development and accelerate the path toward clinical development Matthew Hammond, Ph.D., Principal at RA Capital Management, and Dan Becker, [...]